Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: association to tumor derived alpha-N-acetylgalactosaminidase activity.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Letters

• Publication date

  2009-10-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2009.04.001PMID 19394758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.

  2008cited by this paper
• RETRACTED ARTICLE: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF

  2008cited by this paper
• Retracted: Immunotherapy of metastatic breast cancer patients with vitamin D‐binding protein‐derived macrophage activating factor (GcMAF)

  2008cited by this paper
• Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer.

  2007cited by this paper
• Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers.

  2007cited by this paper
• Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.

  2007cited by this paper
• Transthyretin: no association between serum levels or gene variants and schizophrenia.

  2007cited by this paper
• Melanoma biology and new targeted therapy

  2007cited by this paper
• Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen.

  2006cited by this paper
• Cutaneous malignant melanoma.

  2006cited by this paper
• A proteomic approach for the characterization of C677T mutation of the human gene methylenetetrahydrofolate reductase

  2006cited by this paper
• Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins.

  2005cited by this paper
• Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation.

  2005cited by this paper
• Heat‐shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis

  2005cited by this paper
• Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients.

  2005cited by this paper
• Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting.

  2005cited by this paper
• Blue silver: A very sensitive colloidal Coomassie G‐250 staining for proteome analysis

  2004cited by this paper
• 967. Angiotensinogen Inhibits Growth and Angiogenesis of Human Mammary Carcinoma and Prevents Pulmonary Metastasis of Murine Melanoma Cancer

  2004cited by this paper
• Identification of tumor‐associated plasma biomarkers using proteomic techniques: From mouse to human

  2004cited by this paper
• Therapeutic potential of vitamin D-binding protein.

  2004cited by this paper
• Increase of melanogenesis by retinoic acid: an ultrastructural and morphometric study.

  2004cited by this paper
• Hepatic Synthesis, Maturation and Complex Formation between Retinol-Binding Protein and Transthyretin

  2002cited by this paper
• Preparation of Gc protein-derived macrophage activating factor (GcMAF) and its structural characterization and biological activities.

  2002cited by this paper
• Human melanomas of fibroblast and epithelial morphology differ widely in their ability to synthesize retinyl esters.

  2002cited by this paper
• Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation.

  2002cited by this paper
• Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis.

  2002cited by this paper
• The Transthyretin—Retinol-Binding Protein Complex

  2000cited by this paper
• The transthyretin-retinol-binding protein complex.

  2000cited by this paper
• Computer analysis of 2-D images.

  1999cited by this paper
• Computer Analysis of 2-D Images

  1999cited by this paper
• The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP.

  1999cited by this paper
• Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice.

  1999cited by this paper
• Future trends: a new generation of retinoids.

  1998cited by this paper
• Properties of an alpha-galactosidase, and structure of its gene galA, within an alpha-and beta-galactoside utilization gene cluster of the hyperthermophilic bacterium Thermotoga maritima.

  1998cited by this paper
• Properties of an α-galactosidase, and structure of its gene galA, within an α- and β-galactoside utilization gene cluster of the hyperthermophilic bacterium Thermotoga maritima

  1998cited by this paper
• Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.

  1997cited by this paper
• Prognostic utility of serum alpha-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients.

  1997cited by this paper
• Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients.

  1996cited by this paper
• Role of vitamin D3-binding protein in activation of mouse macrophages.

  1996cited by this paper
• The relationship between susceptibility to retinoic acid treatment and protein kinase C alpha expression in murine melanoma cell lines.

  1996cited by this paper
• The Relationship between Susceptibility to Retinoic Acid Treatment and Protein Kinase Cα Expression in Murine Melanoma Cell Lines

  1996cited by this paper
• Effects of vitamin D

  1985cited by this paper

• The Future of Tumor Markers: Advancing Early Malignancy Detection Through Omics Technologies, Continuous Monitoring, and Personalized Reference Intervals

  2025cites this paper
• Selection of optimal protein sets as serological tumor marker signatures.

  2025cites this paper
• Comparative Study on the Role of Nagalase Expression in Different Cancer Cell Lines

  2023cites this paper
• Genomic and proteomic findings in early melanoma and opportunities for early diagnosis

  2022cites this paper
• Effect of Phlorotannins from Brown Algae Costaria costata on α-N-Acetylgalactosaminidase Produced by Duodenal Adenocarcinoma and Melanoma Cells

  2022cites this paper
• Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers

  2022cites this paper
• Mapping the Melanoma Plasma Proteome (MPP) Using Single-Shot Proteomics Interfaced with the WiMT Database

  2021cites this paper
• Consumption of an Extremely Biodiverse Probiotic and a Supplement based on Microbial Chondroitin Sulfate is Associated with Very Low Serum Alpha-N-acetylgalactosaminidase (Nagalase) Activity and Decrease of C-reactive Protein Values

  2020cites this paper
• Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: a case report

  2018cites this paper
• 10-18-2010 Vitamin D Binding Protein-Macrophage Activating Factor Directly Inhibits Proliferation , Migration , and uPAR Expression of Prostate Cancer Cells

  2018cites this paper
• Multiple exo-glycosidases in human serum as detected with the substrate DNP-α-GalNAc. II. Three α-N-acetylgalactosaminidase-like activities in the pH 5 to 8 region

  2017cites this paper
• Targeted Proteomics Predicts a Sustained Complete-Response after Transarterial Chemoembolization and Clinical Outcomes in Patients with Hepatocellular Carcinoma: A Prospective Cohort Study.

  2017cites this paper
• Melanoma Biomarkers in Circulation

  2017cites this paper
• Alteration of α-N-acetylgalactosaminidase (nagalase) concentration in alcohol-dependent individuals without liver disease, during the detoxification therapy.

  2017cites this paper
• Is α-N-acetylgalactosaminidase the key to curing cancer? A mini-review and hypothesis.

  2017cites this paper
• shRNA-mediated downregulation of α-N-Acetylgalactosaminidase inhibits migration and invasion of cancer cell lines

  2017cites this paper
• Is chondroitin sulfate responsible for the biological effects attributed to the GC protein-derived Macrophage Activating Factor (GcMAF)?

  2016cites this paper
• Discovery of potential serum protein biomarkers for lymph node metastasis in oral cancer

  2016cites this paper
• Possibilities and limitations of 2DE‐based analyses for identifying low‐abundant tumor markers in human serum and plasma

  2016influential citation
• Proteomics: An Indispensable Tool for Novel Biomarker Identification in Melanoma

  2016cites this paper
• Proteomics and melanoma: a current perspective

  2016cites this paper
• Synthesis of polyhydroxylated piperidine and pyrrolidine peptidomimetics via one-pot sequential lactam reduction/Joullié-Ugi reaction.

  2015cites this paper
• Synthesis of the enantiomers of XYLNAc and LYXNAc: comparison of β-N-acetylhexosaminidase inhibition by the 8 stereoisomers of 2-N-acetylamino-1,2,4-trideoxy-1,4-iminopentitols.

  2014cites this paper
• Nine of 16 stereoisomeric polyhydroxylated proline amides are potent β-N-acetylhexosaminidase inhibitors.

  2014cites this paper
• A Glycal Approach to the Synthesis of Steviamine Analogues

  2014cites this paper
• Identification of candidate serum biomarkers for small cell lung cancer by proteomics analysis.

  2014cites this paper
• Overview of Macrophage Activating Factor and the Nagalase Assay – Potential for Control of Micrometastatic or Early Primary Cancer

  2013cites this paper
• Synthesis of dihydroxymethyl dihydroxypyrrolidines and steviamine analogues from C-2 formyl glycals.

  2013cites this paper
• Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and Therapy Monitoring

  2013cites this paper
• Effects of Gc-Macrophage Activating Factor in Human Neurons; Implications for Treatment of Chronic Fatigue Syndrome

  2013cites this paper
• GC protein-derived macrophage-activating factor decreases α-N-acetylgalactosaminidase levels in advanced cancer patients

  2013cites this paper
• Common variants of the vitamin D binding protein gene and adverse health outcomes

  2013cites this paper
• Comparative Proteomics of Sera From HCC Patients With Different Origins

  2013cites this paper
• Prognostic factors for melanoma progression and metastasis: from Hematoxylin-Eosin to genetics.

  2012cites this paper
• Pharmacological chaperones for human α-N-acetylgalactosaminidase

  2012cites this paper
• Epithelial Ovarian Cancer – Adjuvant Measures with Potential for Slowing Its Spread and Boosting or Restoring its Chemosensitivity

  2012cites this paper
• New vitamin D analogs as potential therapeutics in melanoma

  2012cites this paper
• Scalable syntheses of both enantiomers of DNJNAc and DGJNAc from glucuronolactone: the effect of N-alkylation on hexosaminidase inhibition.

  2012cites this paper
• The immune system--a hidden treasure for biomarker discovery in cutaneous melanoma.

  2012cites this paper
• Proteomics in Melanoma Biomarker Discovery: Great Potential, Many Obstacles

  2011cites this paper
• Gc protein-derived macrophage-activating factor (GcMAF) stimulates cAMP formation in human mononuclear cells and inhibits angiogenesis in chick embryo chorionallantoic membrane assay

  2011cites this paper
• [Circulating prognosis markers in melanoma: proteomic profiling and clinical studies].

  2011cites this paper
• Proteomics-Based Disease Biomarkers

  2011cites this paper
• Serum Proteomic Profiling Reveals Potential Biomarkers for Cutaneous Malignant Melanoma

  2011cites this paper
• Mass spectrometry of peptides and proteins from human blood.

  2011cites this paper
• Differential expression of haptoglobin isoforms in chronic active hepatitis, cirrhosis and HCC related to HBV infection.

  2011cites this paper
• Lenalidomide Restrains Motility and Overangiogenic Potential of Bone Marrow Endothelial Cells in Patients with Active Multiple Myeloma

  2011cites this paper
• Altered Levels of Serum Haptoglobin and Apo A-I in Schizophrenia (Perubahan Paras Haptoglobin dan Apo A-I Serum dalam Skizofrenia)

  2011cites this paper
• The diagnostic and prognostic role of cytokines in colon cancer

  2011cites this paper
• Enantiomeric 2-acetamido-1,4-dideoxy-1,4-iminoribitols as potential pyrrolidine hexosaminidase inhibitors

  2011cites this paper
• 2-Acetamido-N-benzyl-1,4-imino-1,2,4-trideoxy-l-xylitol (N-benzyl-l-XYLNAc)

  2010cites this paper
• Synthesis of 2-acetamido-1,2-dideoxy-d-galacto-nojirimycin [DGJNAc] from d-glucuronolactone: the first sub-micromolar inhibitor of α-N-acetylgalactosaminidases

  2010cites this paper
• Precipitation and selective extraction of human serum endogenous peptides with analysis by quadrupole time-of-flight mass spectrometry reveals posttranslational modifications and low-abundance peptides

  2010cites this paper
• Synthesis and glycosidase inhibition of the enantiomer of (-)-steviamine, the first example of a new class of indolizidine alkaloid.

  2010cites this paper
• Vitamin D Binding Protein-Macrophage Activating Factor Directly Inhibits Proliferation, Migration, and uPAR Expression of Prostate Cancer Cells

  2010cites this paper